COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-072X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review ; day:8 ; month:2 ; year:2021 ; pages:1-15
Archives of microbiology ; (8.2.2021), 1-15
- Creator
-
Raj, C. T. Dhanya
Kandaswamy, Dinesh Kumar
Danduga, Ravi Chandra Sekhara Reddy
Rajasabapathy, Raju
James, Rathinam Arthur
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00203-021-02183-z
- URN
-
urn:nbn:de:101:1-2021030320425642758821
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.11.0006, 11:22 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Raj, C. T. Dhanya
- Kandaswamy, Dinesh Kumar
- Danduga, Ravi Chandra Sekhara Reddy
- Rajasabapathy, Raju
- James, Rathinam Arthur
- SpringerLink (Online service)
Other Objects (12)
Arteriogenesis – molecular regulation, pathophysiology and therapeutics, 1
Normal pressure hydrocephalus : pathology, pathophysiology, diagnostics, therapeutics and clinical course
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review
Modified nucleic acids: replication, evolution, and next-generation therapeutics
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
IABP: history-evolution-pathophysiology-indications: what we need to know
Transplantation therapeutics
Arithmetical therapeutics
Arteriogenesis – molecular regulation, pathophysiology and therapeutics, 1
Normal pressure hydrocephalus : pathology, pathophysiology, diagnostics, therapeutics and clinical course
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review
Modified nucleic acids: replication, evolution, and next-generation therapeutics
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
IABP: history-evolution-pathophysiology-indications: what we need to know
Transplantation therapeutics
Arithmetical therapeutics
Arteriogenesis – molecular regulation, pathophysiology and therapeutics, 1
Normal pressure hydrocephalus : pathology, pathophysiology, diagnostics, therapeutics and clinical course
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review
Modified nucleic acids: replication, evolution, and next-generation therapeutics
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
IABP: history-evolution-pathophysiology-indications: what we need to know
Transplantation therapeutics